Whales with a lot of money to spend have taken a noticeably bullish stance on CME Gr.
Looking at options history for CME Gr CME we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 19% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $2,422,975 and 10, calls, for a total amount of $602,430.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $300.0 for CME Gr over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for CME Gr's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CME Gr's whale activity within a strike price range from $85.0 to $300.0 in the last 30 days.
CME Gr Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
CME | PUT | TRADE | NEUTRAL | 01/17/25 | $68.4 | $65.0 | $66.5 | $300.00 | $1.9M | 0 | 300 |
CME | CALL | TRADE | BULLISH | 01/17/25 | $154.1 | $152.5 | $154.1 | $85.00 | $154.1K | 5 | 30 |
CME | PUT | TRADE | BULLISH | 01/17/25 | $16.8 | $16.4 | $16.55 | $250.00 | $87.7K | 7 | 81 |
CME | CALL | TRADE | BULLISH | 01/17/25 | $139.1 | $137.7 | $139.1 | $100.00 | $69.5K | 3 | 30 |
CME | CALL | TRADE | NEUTRAL | 01/17/25 | $140.3 | $137.7 | $139.1 | $100.00 | $69.5K | 3 | 25 |
About CME Gr
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Having examined the options trading patterns of CME Gr, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is CME Gr Standing Right Now?
- With a volume of 514,277, the price of CME is down -0.14% at $239.13.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 48 days.
Professional Analyst Ratings for CME Gr
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $258.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Barclays persists with their Equal-Weight rating on CME Gr, maintaining a target price of $257. * An analyst from Keefe, Bruyette & Woods persists with their Market Perform rating on CME Gr, maintaining a target price of $260.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CME Gr, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.